BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 12829126)

  • 1. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
    Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis.
    Lee CM; Lee RJ; Hammond E; Tsodikov A; Dodson M; Zempolich K; Gaffney DK
    Gynecol Oncol; 2004 Apr; 93(1):209-14. PubMed ID: 15047238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix.
    Loncaster JA; Cooper RA; Logue JP; Davidson SE; Hunter RD; West CM
    Br J Cancer; 2000 Sep; 83(5):620-5. PubMed ID: 10944602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma.
    Gallo O; Masini E; Bianchi B; Bruschini L; Paglierani M; Franchi A
    Hum Pathol; 2002 Jul; 33(7):708-14. PubMed ID: 12196922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclooxygenase-2 and vascular endothelial growth factor in pancreatic tumors.
    Aoki T; Nagakawa Y; Tsuchida A; Kasuya K; Kitamura K; Inoue K; Ozawa T; Koyanagi Y; Itoi T
    Oncol Rep; 2002; 9(4):761-5. PubMed ID: 12066205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 expression in an adenoid cystic carcinoma of the uterine cervix.
    Ishiko O; Sumi T; Yoshida H; Tokuyama O; Wakasa K; Haba T; Ogita S
    Oncol Rep; 2001; 8(5):1023-5. PubMed ID: 11496309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervix.
    Lee IJ; Park KR; Lee KK; Song JS; Lee KG; Lee JY; Cha DS; Choi HI; Kim DH; Deung YK
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):768-79. PubMed ID: 12377329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-derived endothelial cell growth factor as a prognostic factor for radiotherapy outcome in patients with adenocarcinoma of the uterine cervix.
    Ryu SY; Oka K; Tsujii H; Suzuki Y; Nakano T
    Gynecol Oncol; 2003 Jun; 89(3):414-9. PubMed ID: 12798704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma.
    Cho NH; Kim YB; Park TK; Kim GE; Park K; Song KJ
    Gynecol Oncol; 2003 Nov; 91(2):346-53. PubMed ID: 14599865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy.
    Gaffney DK; Holden J; Davis M; Zempolich K; Murphy KJ; Dodson M
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1213-7. PubMed ID: 11286825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
    Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS
    Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix.
    Lee CM; Shrieve DC; Zempolich KA; Lee RJ; Hammond E; Handrahan DL; Gaffney DK
    Gynecol Oncol; 2005 Nov; 99(2):415-21. PubMed ID: 16157365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma.
    Pan J; Tang T; Xu L; Lu JJ; Lin S; Qiu S; Chen G; K Tham IW
    Head Neck; 2013 Sep; 35(9):1238-47. PubMed ID: 22972415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucinous colon carcinomas with microsatellite instability have a lower microvessel density and lower vascular endothelial growth factor expression.
    Wendum D; Boëlle PY; Rigau V; Sebbagh N; Olschwang S; Mourra N; Parc R; Trugnan G; Masliah J; Fléjou JF
    Virchows Arch; 2003 Feb; 442(2):111-7. PubMed ID: 12596060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: a potential predictor of poor survival.
    Kim GE; Kim YB; Cho NH; Chung HC; Pyo HR; Lee JD; Park TK; Koom WS; Chun M; Suh CO
    Clin Cancer Res; 2004 Feb; 10(4):1366-74. PubMed ID: 14977838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 expression and angiogenesis in colorectal cancer.
    Xiong B; Sun TJ; Yuan HY; Hu MB; Hu WD; Cheng FL
    World J Gastroenterol; 2003 Jun; 9(6):1237-40. PubMed ID: 12800231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study.
    Tangjitgamol S; Ramirez PT; Sun CC; See HT; Jhingran A; Kavanagh JJ; Deavers MT
    Int J Gynecol Cancer; 2005; 15(4):646-56. PubMed ID: 16014119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in Chinese patients with esophageal squamous cell carcinoma.
    Cui Y; Dong C; Wu BQ; Duan XC; Shi G; Gong M; Wang TY
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C44-8. PubMed ID: 26323923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mRNA expression of cyclo-oxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in human breast cancer.
    Kirkpatrick K; Ogunkolade W; Elkak A; Bustin S; Jenkins P; Ghilchik M; Mokbel K
    Curr Med Res Opin; 2002; 18(4):237-41. PubMed ID: 12201625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of vascular endothelial growth factor in adenocarcinomas of the uterine cervix and its relation to angiogenesis and p53 and c-erbB-2 protein expression.
    Lee JS; Kim HS; Jung JJ; Lee MC; Park CS
    Gynecol Oncol; 2002 Jun; 85(3):469-75. PubMed ID: 12051876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.